Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Wijngaard currently holds 9,501 shares of Hepion Pharmaceuticals, Inc. (HEPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Wijngaard has been a net buyer of HEPA stock. They have purchased $92.4K and sold $0 worth of shares.
Peter Wijngaard's most recent insider trade was on Nov 27, 2023, when they purchased 2,500 shares at $3.05 per share.
Peter Wijngaard serves as Executive at Hepion Pharmaceuticals, Inc. (HEPA). They have executed 18 insider transactions totaling $92.4K over their tenure at the company.
Peter Wijngaard holds the position of Executive at Hepion Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Peter Wijngaard has shown a buying trading pattern, with $92.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Peter Wijngaard was on Dec 27, 2019, when they sold $19.0M worth of MDCO shares. This transaction involved 224,341 shares at $84.78 per share.
Peter Wijngaard currently owns 9,501 shares of Hepion Pharmaceuticals, Inc. (HEPA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Wijngaard's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Wijngaard has 18 Form 4 filings on record as an insider at Hepion Pharmaceuticals, Inc..
Set alerts for Peter Wijngaard and 40,000+ other insiders.